WallStreetZenWallStreetZen

NASDAQ: NPCE
Neuropace Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Neuropace earnings were -$25.9M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest NPCE earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$8.7M, up 31.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NPCE reported annual earnings of -$27.1M, with -17.6% growth.

NPCE earnings history

Current Revenue
$88.6M
Current Earnings
-$25.9M
Current Profit Margin
-29.3%

NPCE Return on Equity

Current Company
-168.6%
Current Industry
15.2%
Current Market
32.2%
NPCE's Return on Equity (-168.6%)... subscribe to Premium to read more.
High Return on Equity Performance

NPCE undefined

Current Company
-25.5%
Current Industry
8.9%
NPCE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NPCE announces earnings.

NPCE undefined

Current Company
-19.51%
Current Industry
10.6%
NPCE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NPCE vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NPCE-$15.52M-$25.94MN/A-$0.83
CLPT-$20.17M-$22.22MN/A-$0.81
TCMD$30.43M$15.11M-2.60%$0.63
BWAY$9.85M$5.34M+1,400.00%$0.30
VMD$47.08M$13.98M-13.65%$0.36
View Top Medical Device Stocks

Neuropace Earnings Reports & History FAQ

What were Neuropace's earnings last quarter?

On NPCE's earnings call on Invalid Date, Neuropace (NASDAQ: NPCE) reported Q2 2025 earnings per share (EPS) of -$0.26, up 0% year over year. Total NPCE earnings for the quarter were -$8.65 million. In the same quarter last year, Neuropace's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Neuropace stock.

Is Neuropace profitable or losing money?

As of the last Neuropace earnings report, Neuropace is currently losing money. Neuropace's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$25.94 million, a 13.23% decrease year over year.

What was NPCE's earnings growth in the past year?

As of Neuropace's earnings date in Invalid Date, Neuropace's earnings has grown year over year. NPCE earnings in the past year totalled -$25.94 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.